These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11939133)

  • 21. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The ANMCO (National Association of Hospital Cardiologists) in a changing health care system. Consensus development of the Organizing Symposium of the XXXI National Congress of Cardiology--ANMCO; Florence, May 21, 2000].
    Ital Heart J Suppl; 2000 Dec; 1(12):1533-44. PubMed ID: 11221582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SNP databases and pharmacogenetics: great start, but a long way to go.
    Marsh S; Kwok P; McLeod HL
    Hum Mutat; 2002 Sep; 20(3):174-9. PubMed ID: 12203989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base.
    Klein TE; Chang JT; Cho MK; Easton KL; Fergerson R; Hewett M; Lin Z; Liu Y; Liu S; Oliver DE; Rubin DL; Shafa F; Stuart JM; Altman RB
    Pharmacogenomics J; 2001; 1(3):167-70. PubMed ID: 11908751
    [No Abstract]   [Full Text] [Related]  

  • 27. Designing and implementing special-purpose databases: lessons from the pharmacogenetic network.
    Nadkarni P; Sun K; Wiepert M
    Pharmacogenomics; 2002 Sep; 3(5):687-96. PubMed ID: 12223053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics: the bioethical problem of DNA investment banking.
    Corrigan OP; Williams-Jones B
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):550-65. PubMed ID: 16980194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics research network and knowledge base second scientific meeting.
    Davis AF; Long RM
    Pharmacogenomics J; 2002; 2(5):293-6. PubMed ID: 12439735
    [No Abstract]   [Full Text] [Related]  

  • 30. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPIDAUROS Biotechnologie AG.
    Arnold HP; Kluge P; Mauch S
    Pharmacogenomics; 2005 Jul; 6(5):535-8. PubMed ID: 16014003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics and pharmacoepidemiology.
    Jones JK
    Pharmacoepidemiol Drug Saf; 2001; 10(5):457-61. PubMed ID: 11802592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML.
    Rubin DL; Hewett M; Oliver DE; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():88-99. PubMed ID: 11928521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation mining experiments in the pharmacogenomics domain.
    Rinaldi F; Schneider G; Clematide S
    J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Company profile: PGXIS Ltd.
    McCarthy A
    Pharmacogenomics; 2011 Sep; 12(9):1253-6. PubMed ID: 21919604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
    Hernandez-Boussard T; Whirl-Carrillo M; Hebert JM; Gong L; Owen R; Gong M; Gor W; Liu F; Truong C; Whaley R; Woon M; Zhou T; Altman RB; Klein TE
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D913-8. PubMed ID: 18032438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meeting of minds: interdisciplinary research in the health sciences in Canada.
    Hall JG; Bainbridge L; Buchan A; Cribb A; Drummond J; Gyles C; Hicks TP; McWilliam C; Paterson B; Ratner PA; Skarakis-Doyle E; Solomon P
    CMAJ; 2006 Sep; 175(7):763-71. PubMed ID: 17001059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
    Mlakar V; Huezo-Diaz Curtis P; Satyanarayana Uppugunduri CR; Krajinovic M; Ansari M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the PharmGKB knowledge base as a resource for efficiently assessing the clinical validity and utility of pharmacogenetic assays.
    Kawamoto K; Orlando LA; Voora D; Lobach DF; Joy S; Cho A; Ginsburg GS
    AMIA Annu Symp Proc; 2009 Nov; 2009():307-11. PubMed ID: 20351870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.